Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics.

Source:http://linkedlifedata.com/resource/pubmed/id/14521419

J. Med. Chem. 2003 Oct 9 46 21 4572-85

Download in:

View as

General Info

PMID
14521419